Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;38(1):34-42.
doi: 10.3803/EnM.2022.1649. Epub 2023 Feb 16.

Overcoming Therapeutic Inertia as the Achilles' Heel for Improving Suboptimal Diabetes Care: An Integrative Review

Affiliations
Review

Overcoming Therapeutic Inertia as the Achilles' Heel for Improving Suboptimal Diabetes Care: An Integrative Review

Boon-How Chew et al. Endocrinol Metab (Seoul). 2023 Feb.

Abstract

The ultimate purpose of diabetes care is achieving the outcomes that patients regard as important throughout the life course. Despite advances in pharmaceuticals, nutraceuticals, psychoeducational programs, information technologies, and digital health, the levels of treatment target achievement in people with diabetes mellitus (DM) have remained suboptimal. This clinical care of people with DM is highly challenging, complex, costly, and confounded for patients, physicians, and healthcare systems. One key underlying problem is clinical inertia in general and therapeutic inertia (TI) in particular. TI refers to healthcare providers' failure to modify therapy appropriately when treatment goals are not met. TI therefore relates to the prescribing decisions made by healthcare professionals, such as doctors, nurses, and pharmacists. The known causes of TI include factors at the level of the physician (50%), patient (30%), and health system (20%). Although TI is often multifactorial, the literature suggests that 28% of strategies are targeted at multiple levels of causes, 38% at the patient level, 26% at the healthcare professional level, and only 8% at the healthcare system level. The most effective interventions against TI are shorter intervals until revisit appointments and empowering nurses, diabetes educators, and pharmacists to review treatments and modify prescriptions.

Keywords: Diabetes mellitus; Medication adherence; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

Kamlesh Khunti chairs the American Diabetes Association Overcoming Therapeutic Inertia initiative. Kamlesh Khunti has acted as a consultant, speaker, or received grants for investigator-initiated studies from Astra Zeneca, Bayer, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, and Applied Therapeutics. No potential conflict of interest relevant to this article was reported by Boon-How Chew, Barakatun-Nisak Mohd-Yusof, and Pauline Siew Mei Lai.

Figures

Fig. 1.
Fig. 1.
The “double valleys” of challenges in diabetes care for good outcomes. aPatient’s favourable outcomes depend on self-management and health behaviours such as that enhance physical health and emotional resilience stemming from will power and health beliefs; bPhysicians performance depends on knowledge in diabetes care and attitudes of the physician towards patients under their care; cGood outcomes are defined as achievement of treatment targets, healthy lifestyles, and good quality of life; dPoor outcomes are defined as the opposite of the good outcomes; eThis attitude is affected by the attitudes of the treating physicians and delivery of the healthcare services; fPatient’s health behaviours are formed from health beliefs, own health knowledge (literacy) and that of their physicians that may affect patient’s motivation.

Similar articles

Cited by

References

    1. International Diabetes Federation . 10th ed. Brussels: IDF; 2021. IDF Diabetes Atlas 2021. [cited 2023 Feb 9]. Available from: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_E.... - PubMed
    1. Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS) Diabetes Care. 2009;32:227–33. - PMC - PubMed
    1. Goh CC, Koh KH, Goh S, Koh Y, Tan NC. Achieving triple treatment goals in multi-ethnic Asian patients with type 2 diabetes mellitus in primary care. Malays Fam Physician. 2018;13:10–8. - PMC - PubMed
    1. Khunti K, Gomes MB, Pocock S, Shestakova MV, Pintat S, Fenici P, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. 2018;20:427–37. - PMC - PubMed
    1. Edelman SV, Polonsky WH. Type 2 diabetes in the real world: the elusive nature of glycemic control. Diabetes Care. 2017;40:1425–32. - PubMed

Publication types

MeSH terms